BackG&E Herbal Biotechnology , Ltd. Overview

G&E Herbal Biotechnology , Ltd. Common Stock

Track G&E Herbal Biotechnology , Ltd.'s common stock ($640M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$637.20M
↑ 0.00% YoYΔ $0.00 vs prior year quarter

Peer trimmed avg / median

Loading

G&E Herbal Biotechnology , Ltd. Common Stock History

Loading

G&E Herbal Biotechnology , Ltd. vs. peers: Common Stock Comparison

Loading

G&E Herbal Biotechnology , Ltd. Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

G&E Herbal Biotechnology , Ltd. (4911.TWO) FAQ

As of the most recent data (June 2026), 4911.TWO shows a common stock of $640M. That compares with $640M in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4911.TWO's common stock is now $640M (was $640M) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether G&E Herbal Biotechnology , Ltd. is outperforming or lagging.

Tracking 4911.TWO's common stock over time shows whether G&E Herbal Biotechnology , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $640M That compares with $640M in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has G&E Herbal Biotechnology , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $640M) with ownership activity and broader fundamentals.

G&E Herbal Biotechnology , Ltd.'s common stock is $640M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.